Xconomy National

by in

Entry	Author	Date	Location
Amicus Counts on “Chaperone” Tech to Enhance Rare Disease Treatments	Arlene Weintraub	01/11/12	New York
Shire Finds Big Value in Rare Diseases, and a Strong Growth Path for its Boston Unit	Arlene Weintraub	05/12/11	New York
Edimer, Third Rock’s Bet on Rare Diseases, Aims to Begin First Human Tests	Ryan McBride	03/15/11	Boston
Genzyme Rival Seeks European Approval	Ryan McBride	11/24/09	Boston
Genzyme Says Supplies, Sales of Two Enzyme Drugs Will Be Even Lower Than Previously Predicted	Wade Roush	09/23/09	Boston
Genzyme Oral Pill for Gaucher’s Succeeds in Trial, Aims to Extend Key Revenue Stream	Ryan McBride	02/20/09	Boston
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event	Ryan McBride	12/04/08	Boston
Page 1 of 1